Table 3—

Malignancies from specific sites in men and women with type 2 diabetes and in the overall cohort

Site-specific cancerMenWomenTotal
All-cause mortality1.28 (1.21–1.35)1.39 (1.32–1.46)1.33 (1.28–1.38)
All malignancies1.07 (0.97–1.19)1.16 (1.02–1.30)1.11 (1.02–1.20)
Oropharyngeal cancer1.22 (0.67–2.05)0.001.12 (0.61–1.88)
Digestive tract1.20 (1.01–1.42)1.19 (0.97–1.44)1.19 (1.05–1.35)
 Esophagus0.78 (0.34–1.54)0.90 (0.19–2.62)0.81 (0.40–1.45)
 Stomach1.16 (0.77–1.68)1.15 (0.70–1.77)1.15 (0.85–1.53)
 Colon and rectum1.18 (0.85–1.60)0.78 (0.50–1.16)0.99 (0.77–1.27)
 Liver1.80 (1.29–2.46)1.97 (1.26–2.91)1.86 (1.43–2.38)
 Biliary tract1.23 (0.40–2.86)1.45 (0.66–2.75)1.36 (0.74–2.29)
 Pancreas0.90 (0.46–1.57)1.78 (1.13–2.67)1.33 (0.93–1.85)
Respiratory intrathoracic organs0.87 (0.71–1.06)1.28 (0.85–1.87)0.94 (0.78–1.11)
 Larynx0.58 (0.21–1.26)0.000.51 (0.19–1.12)
 Lung, trachea, and bronchi0.91 (0.74–1.11)1.31 (0.84–1.95)0.97 (0.80–1.16)
Reproductive system in women1.25 (0.99–1.55)
 Breast1.40 (1.06–1.81)
 Uterus1.08 (0.54–1.93)
Reproductive system in men1.07 (0.75–1.48)
 Prostate1.04 (0.72–1.45)
Urinary tract1.24 (0.88–1.72)1.04 (0.50–1.92)1.20 (0.88–1.60)
 Bladder1.33 (0.83–2.01)1.50 (0.55–3.26)1.36 (0.91–1.98)
 Kidney1.14 (0.64–1.88)0.72 (0.20–1.84)1.01 (0.61–1.58)
  • Data are SMR (95% CI). Boldface type represents SMR significantly different from unity.